Delivery Order SPE2DB24D2013-SPE2DB24FCGTK
- Not listed
- This federal contract award, valued at $2,967.37, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a pharmaceutical product. This is a delivery order under the company's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical...
- This federal contract award, valued at $10,148.01, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml. The contract is a firm fixed-price delivery order with an ultimate completion date of April 21, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation indicated. This award is part of Amerisourcebergen's larger Indefinite Delivery...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $7,049.22, is for the delivery of Ozempic 2 mg/dose (8 mg/3 ml) 3ml, a specialty medication. This award is part of Amerisourcebergen's larger $999,999,999 IDC with the DLA, which serves as a primary vehicle for the company to provide a comprehensive range of...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml. The $4,389.43 firm fixed price contract is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an ultimate completion date of July 12, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication. The fixed-price delivery order, valued at $1,451.35, has a completion date of June 6, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $1,104.69, is for the delivery of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml medication. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC serves as the primary vehicle for Cencora,...
- This federal contract award is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml to the Defense Logistics Agency (DLA). The $1,741.62 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has an ultimate completion date of April 29, 2024. This is a delivery order placed against Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication to the Defense Logistics Agency (DLA). The $4,350.63 firm-fixed-price delivery order has a completion date of December 16, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies, including...
- This federal contract award is for the delivery of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml to the Defense Logistics Agency (DLA). The $8,338.01 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on February 21, 2024 with a completion date of February 22, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $1,668.06, is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml to support federal healthcare programs. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to provide a comprehensive range...
- SPE2DB24D2013Indefinite Delivery Contract
- SPE2DB24D2013-SPE2DB24FCGTKDelivery Order
This federal contract award is for $2,309.43 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to provide Ozempic 1 mg/dose (4 mg/3 ml) 3 ml to the Defense Logistics Agency (DLA). The award is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999.00 and runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, including the Department of Defense and Department of Veterans Affairs healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 4/30/24 |